TTOO Historical Balance Sheet
TTOO Stock | USD 5.14 0.08 1.58% |
Trend analysis of T2 Biosystms balance sheet accounts such as Other Liabilities of 5.9 M, Property Plant And Equipment Net of 9.8 M, Net Debt of 35.5 M or Accounts Payable of 1.6 M provides information on T2 Biosystms' total assets, liabilities, and equity, which is the actual value of T2 Biosystms to its prevalent stockholders. By breaking down trends over time using T2 Biosystms balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining T2 Biosystms latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether T2 Biosystms is a good buy for the upcoming year.
T2 Biosystms Inventory |
|
TTOO |
About TTOO Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of T2 Biosystms at a specified time, usually calculated after every quarter, six months, or one year. T2 Biosystms Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of T2 Biosystms and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which TTOO currently owns. An asset can also be divided into two categories, current and non-current.
T2 Biosystms Balance Sheet Chart
T2 Biosystms Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how T2 Biosystms uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, T2 Biosystms' Cash is very stable compared to the past year. As of the 3rd of June 2024, Non Current Assets Total is likely to grow to about 11.6 M, while Short and Long Term Debt Total is likely to drop about 42 M. Add Fundamental
Total Assets
Total assets refers to the total amount of T2 Biosystms assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in T2 Biosystms books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on T2 Biosystms balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of T2 Biosystms are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from T2 Biosystms' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.At this time, T2 Biosystms' Cash is very stable compared to the past year. As of the 3rd of June 2024, Non Current Assets Total is likely to grow to about 11.6 M, while Short and Long Term Debt Total is likely to drop about 42 M.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 57.1M | 59.2M | 49.5M | 42.0M | Total Assets | 60.5M | 34.4M | 34.8M | 43.7M |
T2 Biosystms balance sheet Correlations
Click cells to compare fundamentals
T2 Biosystms Account Relationship Matchups
High Positive Relationship
High Negative Relationship
T2 Biosystms balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 28.5M | 79.1M | 60.5M | 34.4M | 34.8M | 43.7M | |
Short Long Term Debt Total | 44.8M | 55.8M | 57.1M | 59.2M | 49.5M | 42.0M | |
Other Current Liab | 13.6M | 6.4M | 7.2M | 7.7M | 11.5M | 7.1M | |
Total Current Liabilities | 60.6M | 9.8M | 11.7M | 10.5M | 56.2M | 59.0M | |
Total Stockholder Equity | (34.0M) | 8.7M | (12.9M) | (40.0M) | (28.0M) | (26.6M) | |
Other Liab | 46K | 4.8M | 4.6M | 4.9M | 5.6M | 5.9M | |
Property Plant And Equipment Net | 9.2M | 14.8M | 14.4M | 13.3M | 9.1M | 9.8M | |
Net Debt | 33.7M | 39.0M | 34.9M | 48.9M | 33.8M | 35.5M | |
Retained Earnings | (376.2M) | (423.0M) | (472.2M) | (534.5M) | (584.3M) | (555.1M) | |
Accounts Payable | 3.8M | 2.1M | 2.8M | 1.3M | 1.5M | 1.6M | |
Cash | 11.0M | 16.8M | 22.2M | 10.3M | 15.7M | 28.6M | |
Non Current Assets Total | 9.6M | 25.5M | 16.1M | 15.0M | 9.7M | 11.6M | |
Cash And Short Term Investments | 11.0M | 42.2M | 32.2M | 10.3M | 15.7M | 31.0M | |
Common Stock Total Equity | 36K | 44K | 51K | 147K | 169.1K | 177.5K | |
Common Stock Shares Outstanding | 9.1K | 24.3K | 31.8K | 51.0K | 2.6M | 2.7M | |
Liabilities And Stockholders Equity | 28.5M | 79.1M | 60.5M | 34.4M | 34.8M | 43.7M | |
Non Current Liabilities Total | 1.9M | 60.6M | 61.8M | 63.9M | 6.7M | 6.3M | |
Other Current Assets | 1.4M | 2.7M | 3.1M | 2.6M | 3.2M | 1.7M | |
Other Stockholder Equity | 342.1M | 431.5M | 459.2M | 494.6M | 556.3M | 315.0M | |
Total Liab | 62.5M | 70.4M | 73.4M | 74.4M | 62.8M | 50.8M | |
Property Plant And Equipment Gross | 9.2M | 14.8M | 14.4M | 13.3M | 23.9M | 25.1M | |
Total Current Assets | 18.9M | 53.6M | 44.4M | 19.4M | 25.1M | 35.3M | |
Short Term Debt | 42.9M | 1.2M | 1.2M | 1.4M | 42.9M | 45.0M | |
Common Stock | 49K | 147K | 166K | 8K | 4K | 3.8K | |
Property Plant Equipment | 5.8M | 14.8M | 14.4M | 13.3M | 15.3M | 9.5M | |
Net Tangible Assets | (32.1M) | 8.7M | (12.9M) | (40.0M) | (36.0M) | (34.2M) | |
Current Deferred Revenue | 285K | 230K | 518K | 172K | 224K | 212.8K | |
Net Receivables | 2.8M | 5.1M | 5.1M | 2.2M | 1.4M | 2.2M | |
Retained Earnings Total Equity | (266.1M) | (317.2M) | (376.2M) | (423.0M) | (380.7M) | (399.7M) | |
Capital Surpluse | 267.4M | 328.5M | 342.1M | 431.5M | 496.3M | 308.8M | |
Inventory | 3.6M | 3.6M | 3.9M | 4.3M | 4.8M | 2.9M | |
Short Long Term Debt | 40.7M | 42.4M | 42.9M | 41.3M | 47.5M | 27.2M | |
Capital Lease Obligations | 3.9M | 10.5M | 9.4M | 9.6M | 8.2M | 6.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for TTOO Stock analysis
When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 109.92 | Revenue Per Share 1.864 | Quarterly Revenue Growth (0.01) | Return On Assets (1.00) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.